FindTrial
Sign In

A Study on Gene Expression in Osteoarthritis of Knee treated with Rhus toxicodendron 200

A Clinical Study on Gene Expression of Hyaluronan Synthase 2 gene in patients suffering from Osteoarthritis of Knee treated with Rhus toxicodendron in 200th potency - GERT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032824
Enrollment
30
Registered
2021-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

Intervention1: RHUS TOXICODENDRON 200: Rhus Tox will be given in 200th potency in 2 grain lactose at every six hour orally for 90 days Control Intervention1: Not applicable: Not applicable

Sponsors

Sarada Krishna Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of Osteoarthritis of Knee and with symptomatology of Rhus Toxicodendron.

Exclusion criteria

Exclusion criteria: Patients suffering from other severe systemic diseases. Age group: Below 40 yrs and above 70 yrs. Patients with symptoms of medicines other than Rhus Toxicodendron.

Design outcomes

Primary

MeasureTime frame
Rhus Toxicodendron has positive effect on HAS2 geneTimepoint: 2 weeks—

Secondary

MeasureTime frame
Rhus Toxicodendron has effect on genetic levelTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactFareed Ahmed K

Sarada Krishna Homoeopathic Medical College

drwinstonv@gmail.com9443692478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026